16gerM

Germany’s DAX Index: Challenging the U.S. dominance in global portfolios

Key points:

  • Germany is gaining strategic relevance as investors seek diversification away from U.S. policy and fiscal risks—helped by pro-growth reforms and industrial strength.
  • The DAX remains attractively valued relative to the S&P 500, despite its outperformance, and offers exposure to global megatrends through high-quality European names.
  • Mid-cap German equities (MDAX) could present the next opportunity, with domestic reform momentum and innovation-led names poised for a potential catch-up rally.


Note: This content is marketing material.

 

Investors have long treated the U.S. as the anchor of global equity portfolios—but 2025 is putting that conviction to the test.

  • Policy uncertainty is rising, with erratic tariff moves undermining U.S. credibility and complicating long-term corporate planning.
  • Fiscal risks are mounting, as ballooning deficits and political dysfunction force investors to demand higher yields—not out of optimism, but caution.
  • The U.S. dollar is weakening, adding another layer of volatility to global portfolios heavily tilted toward the U.S.

Against this backdrop, investors are starting to question their U.S. equity bias. In contrast, Europe—and Germany in particular—offers a compelling diversification story, grounded in industrial strength, global export exposure, and greater policy stability.

This shift in sentiment is already showing up in the numbers, as evident in the chart below. The DAX has outperformed the S&P 500 year-to-date, highlighting growing investor appetite for diversified, industrial-heavy exposure outside the U.S.

27_CHCA_DAX
 

Despite its YTD outperformance, the DAX remains meaningfully cheaper than the S&P 500 on a forward P/E basis.

  • DAX 1-year forward P/E: ~14-16x
  • S&P 500 1-year forward P/E: ~20–22x
27_CHCA_DAX valuation 

That gap gives Germany headroom to re-rate—especially as macro risks in the U.S. rise and European earnings begin to surprise on the upside.

Tactical rotation or structural re-rating?

Germany isn’t just riding a market wave—it’s stepping into a potential policy renaissance. Recent local elections have opened the door to more business-friendly macro policies, including:

  • Debt brake reform, allowing more public investment in growth.
  • Corporate tax cuts aimed at boosting competitiveness.
  • Deregulation initiatives to accelerate green and digital transitions.

These changes could reshape investor confidence in Germany’s economic trajectory and give the DAX a structural boost beyond short-term rotation flows.

What is the DAX index?

The DAX 40 is Germany’s benchmark stock index, representing 40 of the country’s largest and most liquid companies listed on the Frankfurt Stock Exchange. But this isn’t just about Germany—the DAX is home to global leaders in:

  • Industrial automation (Siemens)
  • Clean energy (E.ON, Siemens Energy)
  • Mobility (Volkswagen, BMW, Mercedes-Benz)
  • Pharmaceuticals (Bayer, Merck)
  • Insurance (Allianz, Munich Re)
  • Consumer goods (Adidas, Henkel)

These companies generate a significant share of their revenue outside Germany, offering international diversification through deeply rooted, export-driven business models.

Here are the DAX constituents by market cap:

27_CHCA_DAX List v2


DAX vs. Wall Street: Familiar themes, different names

For investors accustomed to the S&P 500, the DAX offers exposure to many of the same global megatrends—just through European lenses.

27_CHCA_DAX and SPX
 

Don’t overlook the MDAX

As capital flows broaden, mid-cap German equities are getting harder to ignore. The MDAX, Germany’s mid-cap index comprising 50 companies with a stronger domestic focus, offers exposure to Germany's innovation engine across biotech, automation, defense, and consumer sectors.

Some notable names include:

  • Delivery Hero – Online food delivery platform with global footprint
  • Renk – Defense and mobility systems manufacturer
  • Thyssenkrupp – Engineering conglomerate and green steel play
  • Hensoldt – Defense tech firm specializing in radar and sensor systems
  • Evotec – Biotech company enabling drug discovery
  • Hugo Boss – Leading fashion brand
  • Kion Group – Warehouse automation and logistics systems

With the MDAX still underperforming the DAX YTD, there’s room for a catch-up rally as confidence improves in Germany’s domestic outlook.

What could fuel the next leg higher?

Several macro tailwinds could add fuel to the German equity story:

  • Ceasefire or peace deal in Ukraine, which could ease energy prices and geopolitical risk premiums.
  • Revisions to EU emissions rules, which could delay cost pressures on autos and industrials.
  • Tariff relief from the U.S., especially if election outcomes in 2025 favor trade normalization.
  • Stronger euro helping anchor inflation and support real incomes in the Eurozone.

These developments would provide support to margins, confidence, and capital spending—key ingredients for sustained earnings growth.

What are the risks?

Germany’s equity story isn’t without hurdles. Key risks to monitor include:

  • Structural energy costs: Even with easing tensions, Germany’s post-nuclear energy strategy leaves it exposed to higher input costs.
  • China exposure: Many DAX firms have significant reliance on Chinese demand—any slowdown or trade frictions could weigh on earnings.
  • Cyclical vulnerability: As an export-heavy economy, Germany remains sensitive to global growth shocks and supply chain dislocations.
  • Execution risk on reforms: Political gridlock or failure to implement promised business-friendly measures could undercut the current momentum.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.